Mathew, Ashish J

Real-life Safety Profile of ZRC3197 (Adalimumab Biosimilar) in Indian Patients with Common Rheumatic Diseases. [electronic resource] - The Journal of the Association of Physicians of India May 2017 - 30-32 p. digital

Publication Type: Journal Article

0004-5772


Adalimumab--adverse effects
Antirheumatic Agents--adverse effects
Biosimilar Pharmaceuticals--adverse effects
Female
Humans
India
Male
Rheumatic Diseases--drug therapy